Suchergebnisse - "Beltrán, Belén"

PubPharm (15)

1

Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease

enthalten in: European journal of gastroenterology & hepatology | 2020

von Chaparro, M. | Guerra, I. | Iborra, M. | +28

2

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease : Results From the Eneida Registry

enthalten in: Inflammatory bowel diseases | 2020

von Casanova, M. | Chaparro, M. | Mínguez, M. | +58

CommentIn: Inflamm Bowel Dis. 2020 Mar 4;26(4):617-618. - PMID 31504548

3

Granulocyte-monocyte apheresis : an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis

enthalten in: Scandinavian journal of gastroenterology | 2019

von Rodríguez-Lago, I. | Sempere, L. | Gutiérrez, A. | +15

4

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

enthalten in: Digestive diseases and sciences | 2019

von Chaparro, M. | Barreiro-de Acosta, M. | Echarri, A. | +21

5

Secondary Haemophagocytic Syndrome and Overlapping Immune Reconstitution Syndrome : Life-Threatening Complications of Anti-TNF-α Treatment for Crohn's Disease

enthalten in: The American journal of gastroenterology | 2019

von Sáez-González, E. | Salavert, M. | Cerrillo, E. | +4

6

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

enthalten in: Digestive diseases and sciences | 2018

von Chaparro, M. | Barreiro-de Acosta, M. | Echarri, A. | +21

7

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

enthalten in: Digestive diseases and sciences | 2018

von Chaparro, M. | Barreiro-de Acosta, M. | Echarri, A. | +21

8

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

enthalten in: Digestive diseases and sciences | 2018

von Chaparro, M. | Barreiro-de Acosta, M. | Echarri, A. | +21

9

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

enthalten in: Inflammatory bowel diseases | 2017

von Aguas Peris, M. | Bosó, V. | Navarro, B. | +8

10

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice : comparison between anti-tumour necrosis factor-naïve and non-naïve patients

enthalten in: Journal of gastroenterology | 2017

von Iborra, M. | Pérez-Gisbert, J. | Bosca-Watts, M. | +25

ErratumIn: J Gastroenterol. 2017 Jul;52(7):875-877. - PMID 27885420